Fidelis Capital Partners’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$457K Buy
1,152
+126
+12% +$57K 0.03% 334
2025
Q4
$482K Sell
1,026
-21
-2% -$9.33K 0.04% 313
2025
Q3
$517K Sell
1,047
-129
-11% -$72.9K 0.04% 297
2025
Q2
$736K Buy
1,176
+222
+23% +$103K 0.07% 216
2025
Q1
$426K Sell
954
-148
-13% -$71.9K 0.05% 269
2024
Q4
$573K Buy
1,102
+151
+16% +$78.9K 0.06% 233
2024
Q3
$469K Buy
951
+7
+0.7% +$3.76K 0.06% 244
2024
Q2
$463K Sell
944
-31
-3% -$17.5K 0.07% 221
2024
Q1
$557K Buy
975
+138
+16% +$76K 0.08% 198
2023
Q4
$431K Buy
837
+43
+5% +$22K 0.1% 192
2023
Q3
$364K Buy
794
+92
+13% +$41.2K 0.12% 161
2023
Q2
$306K Sell
702
-23
-3% -$9.26K 0.11% 196
2023
Q1
$269K Buy
725
+89
+14% +$31.8K 0.11% 193
2022
Q4
$207K Buy
+636
New +$199K 0.24% 108

Other funds holding SNPS

Fidelis Capital Partners's SNPS Position: Q1 2026 in Review

Fidelis Capital Partners increased its Synopsys (SNPS) stake by 12% in Q1 2026, buying an estimated $57K and bringing the position to 1,152 shares worth $457K. The position accounts for 0.03% of the portfolio, ranked #334.

Fidelis Capital Partners first reported a position in SNPS in Q4 2022 and has held it in 14 quarters since. The position peaked at $736K in Q2 2025. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Fidelis Capital Partners held 1,152 shares of Synopsys worth $457K as of Q1 2026.
  • Fidelis Capital Partners bought 126 Synopsys shares in Q1 2026, an estimated $57K.
  • Synopsys made up 0.03% of Fidelis Capital Partners's portfolio in Q1 2026, its #334 holding.
  • Fidelis Capital Partners first reported a position in Synopsys in Q4 2022 and has held it in 14 quarters since.
  • Fidelis Capital Partners's Synopsys position peaked at $736K in Q2 2025.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.